NV
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitals | Lancet. Infectious diseases | 2022 | 228 | 451 | |||
| Bacteremia Detection in Second or Subsequent Blood Cultures Among Hospitalized Patients in a Tertiary Care Hospital | JAMA Network Open | 2022 | 231 | 66 | |||
| A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and Vaccination | Viruses | 2022 | 178 | 120 | |||
| Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic | Preventive Medicine | 2021 | 227 | 96 | |||
| Hepatitis C prevalence in the psychiatric setting: cost-effectiveness of scaling-up screening and direct-acting antiviral therapy | JHEP Reports : Innovation in Hepatology | 2021 | 299 | 130 | |||
| Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients | Medical mycology | 2021 | 349 | 1 | |||
| Development and validation of the OUTCoV score to predict the risk of hospitalisation among patients with SARS-CoV-2 infection in ambulatory settings: a prospective cohort study | BMJ Open | 2021 | 285 | 139 | |||
| SARS-CoV-2 testing strategy: A comparison of restricted and extended strategies in a Swiss outpatient cohort from the community and hospital employees | PloS one | 2021 | 214 | 97 | |||
| Determination of antiretroviral drugs for buyers' club in Switzerland using capillary electrophoresis methods | Electrophoresis | 2020 | 287 | 2 | |||
| The Swiss Cheese Prescribing Model for Precision Medicine | American Journal of Medicine | 2020 | 297 | 199 | |||
| How to Develop and Implement a Computerized Decision Support System Integrated for Antimicrobial Stewardship? Experiences From Two Swiss Hospital Systems | Frontiers in digital health | 2020 | 184 | 101 | |||
| Buyers' club : une alternative pour l'accès au traitement ? | Revue médicale suisse | 2020 | 409 | 194 | |||
| Impact of restricting procalcitonin measurements in a Swiss tertiary-care hospital on antibiotic use, clinical outcomes, and costs: An interrupted time-series analysis | Infection Control and Hospital Epidemiology | 2020 | 281 | 83 | |||
| Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs | Swiss Medical Weekly | 2020 | 504 | 352 | |||
| Access to unauthorized hepatitis C generics: Perception and knowledge of physicians, pharmacists, patients and non-healthcare professionals | PLOS ONE | 2019 | 275 | 186 | |||
| Life cycle of a drug – a perspective for policy makers | 2018 | 735 | 10 | ||||
| A buyers' club to improve access to hepatitis C treatment for vulnerable populations | Swiss Medical Weekly | 2018 | 1,229 | 438 | |||
| Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine | The Pharmacogenomics Journal | 2018 | 655 | 271 | |||
| Snapshot of the prescribing practice for the clopidogrel and esomeprazole coprescription and cost evaluation of the application guidelines | Pharmacology research & perspectives | 2016 | 696 | 306 | |||
| Early specialized care after a first unprovoked epileptic seizure | Journal of neurology | 2016 | 668 | 2 | |||
| Drug Pricing Evolution in Hepatitis C | PloS one | 2016 | 1,365 | 609 | |||
| Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis | The Lancet. Psychiatry | 2014 | 542 | 0 | |||
| Effets indésirables des inhibiteurs de la pompe à proton: faut-il craindre de les prescrire au long cours ? | La Revue de médecine interne | 2012 | 762 | 1,691 | |||
| Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study | Clinical infectious diseases | 2011 | 645 | 0 | |||
| Politique du médicament : modéliser l'efficience dans une perspective hospitalière et sociétale au moyen des time series | 2011 | 501 | 1,246 | ||||
| Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures | Infection control and hospital epidemiology | 2011 | 646 | 0 | |||
| Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unit | The Journal of infection | 2009 | 730 | 0 |
